To view the Social Media Release, click here: http://smr.newswire.ca/en/duchesnay-inc/prevegyne-now-available-in-canada
BLAINVILLE, QC, Jan. 26 /CNW Telbec/ - Prevegyne™, a novel and natural treatment to help women overcome their recurrent
Bacterial Vaginosis, is now available in Canada. This announcement was
made by Duchesnay Inc., a specialty pharmaceutical company focused on
women's health and quality of life.
Prevegyne™ is a special controlled-release vaginal tablet formulation
containing ascorbic acid (vitamin C) as the active ingredient. It
treats and prevents Bacterial Vaginosis by acidifying the vaginal fluid
to restore the physiological pH. This mode of action promotes the
growth of protective bacteria (lactobacilli) to the detriment of pathogenic bacteria (such as Gardnerella Vaginalis), which cannot survive in an acidic environment. By ensuring a healthy
and long-lasting balance of the vaginal flora, Prevegyne™ helps prevent
recurrence of the bacterial infection.
Dre Céline Bouchard, Associate Clinical Professor, Université Laval,
Québec, explains that "Bacterial Vaginosis is the most frequent vaginal
infection in women of childbearing age. It is not only associated with
unpleasant symptoms for the women, but it can also be related to
serious health problems such as premature labour, post-surgery
infections and an increased risk of HIV coinfection. The rate of
recurrence is high, i.e. around 30%."
According to Éric Gervais, Duchesnay's Executive Vice-President,
"Prevegyne™ provides an efficient and new solution to reduce the
recurrence of Bacterial Vaginosis, which represents 40% to 50% of all
vaginitis. According to the available data, from 40 to 50% women
treated with antibiotics (e.g. metronidazole, clindamycine) see their
symptoms reoccur within 12 months following treatment. Because of their
special controlled-release formulation, Prevegyne™ vaginal tablets
ensure a long-lasting balance of the bacterial flora and help prevent
recurrence of symptoms."
"Prevegyne™ is available at the pharmacy counter. We recommend that this
product be prescribed by a healthcare professional following a
differential diagnosis of Bacterial Vaginosis. In addition, we provide
a Medical information service to patients, either via a toll-free line,
or by e-mail. They can also visit the web site www.prevegyne.com," concluded Éric Gervais.
About Duchesnay Inc.
Duchesnay Inc., located in the Montreal area, is a specialty pharmaceutical company
dedicated to women's health and quality of life. Duchesnay is also
known as the leading Canadian pharmaceutical company in the research,
development and marketing of safe and effective therapies for pregnant
and lactating women.
/NOTE TO PHOTO EDITORS: Photos accompanying this social media release
are available at http://photos.newswire.ca. Images are free to accredited members of the media/
SOURCE Duchesnay inc.
For further information:
Media Relations: 1 877 833-7734 Christine Walter firstname.lastname@example.org
For more information about Prevegyne™: www.prevegyne.com
Duchesnay Web site: www.duchesnay.com